Showing 501-510 of 20873 results for "".
- Pre-Pregnancy Weight Loss Surgery Type May Affect Child's Early Weight Gainhttps://reachmd.com/news/pre-pregnancy-weight-loss-surgery-type-may-affect-childs-early-weight-gain/2466932/The type of weight loss surgery women undergo before becoming pregnant may affect how much weight their children gain in the first three years of life, suggests a study being presented Monday at ENDO 2024, the Endocrine Society's annual meeting in
- Navigating the Interplay between Genetics, Metformin, and Mental Healthhttps://reachmd.com/news/navigating-the-interplay-between-genetics-metformin-and-mental-health/2483212/Metformin, primarily known for managing diabetes, has drawn interest for its potential association with lower depression risk in type 2 diabetes and its role in mitigating antipsychotic-associated weight gain. Research in an observational cohort suggests that
- DIREM Trial: Time-Restricted Feeding And Diabetes Remissionhttps://reachmd.com/news/direm-trial-diabetes-remission/2487337/Key Takeaways Diabetes remission was observed more often in both active lifestyle arms than with usual care. No significant difference was reported between intermittent fasting plus calorie-carbohydrate restriction and calorie-carbohydrate restriction
- Pharmacist-Led Cardiorenal Risk Optimization in a Diabetes Clinichttps://reachmd.com/news/pharmacist-led-cardiorenal-risk-optimization-in-a-diabetes-clinic/2486656/Key Takeaways A retrospective review in a community diabetes clinic found that specialist pharmacist involvement was associated with significant improvements in modifiable cardiorenal risk factors. Over a median follow-up of 6 months in 246 patients wi
- Advancements in Diabetes Management: Exploring New Pharmacological Strategieshttps://reachmd.com/news/advancements-in-diabetes-management-exploring-new-pharmacological-strategies/2483459/The field of diabetes management is undergoing continuous transformations, offering fresh opportunities for improving patient outcomes across varied demographics. The same incretin (GLP-1 and GIP) pathways that tirzepatide modulates are central to weight regulation a
- Navigating Gender-Specific Cardiovascular Risks in Diabeteshttps://reachmd.com/news/navigating-gender-specific-cardiovascular-risks-in-diabetes/2483094/The interplay between sex and diabetes significantly shapes cardiovascular risk profiles, demanding immediate attention in clinical practice. Clinicians face the challenge of tailoring assessments and interventions to manage these diverse risk patterns effectively, and current major guideli
- Early Statin Therapy: Reducing Cardiovascular Risk in Diabeteshttps://reachmd.com/news/early-statin-therapy-reducing-cardiovascular-risk-in-diabetes/2474865/Recent research confirms that early initiation of statin therapy in diabetes patients notably reduces cardiovascular events. This finding informs clinicians about the importance of integrating early statin intervention into treatment gu
- Repurposing Diabetes Medications for Prostate Cancer Treatmenthttps://reachmd.com/news/repurposing-diabetes-medications-for-prostate-cancer-treatment/2474556/Recent research has unveiled a compelling link between diabetes medications and prostate cancer management, highlighting the potential of drugs targeting peroxisome proliferator-activated receptor gamma (PPARγ) to inhibit tumor growth. For oncologists and endocri
- Addressing Challenges in Managing Severe Diabetic Ketoacidosis in Childrenhttps://reachmd.com/news/addressing-challenges-in-managing-severe-diabetic-ketoacidosis-in-children/2470954/What's New Diabetic ketoacidosis (DKA) remains a pressing challenge in pediatric healthcare, necessitating continuous advancements in management strategies. Significance Understanding and improving management of DKA is critical for healthcare profess
- Scientists Discover a Cause of Lupus and a Possible Way to Reverse Ithttps://reachmd.com/news/scientists-discover-a-cause-of-lupus-and-a-possible-way-to-reverse-it/2467305/Two cellular defects appear to drive disease in lupus VIDEO Jaehyuk Choi, MD, PhD, the Jack W. Graffin Professor, an associate professor of Dermatology and a Northwestern Medicine dermatologist. <